R & D SEARCH Website

Home >> R & D >> Labs at SPARC Dosage form development We apply advances in pharmaceutical technology to create dosage forms that offer a patient benefit. Expertise spans conventional as well as novel drug delivery systems based on established technologies. Several products with a delivery system advantage have earned us a marketplace edge. Conventional Products Tablets Capsules Injectables Complex products Injectables for difficult to formulate products (peptides such as Lupreolide and Octreotide). Depot injectables involving month-long or three-month long drug release. Injectables for liposomal based products (liposomal doxorubicin). Sustained release products (Zeptol CR, Monotrate OD, Prazopress XL (with a micropore based drug dissolution and release) , Urotel XL, Dicorate ER, Latocom OD). Mouth Dissolving tabs (Lonazep MD, Zofer MD). Dry power inhaler systems (Fomtide, Montek, Tiotrop). Soft gel capsules (Susten SCG). Gels 1 2 3 Profile Priority Areas Labs at SPARC SITE MAP   DISCLAIMER   PRIVACY POLICY   INTRANET   FIELD FORCE